PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25876471-4	2014	RESULTS: Both fingolimod doses significantly reduced annualized relapse rate in patients that received prior interferon-beta or glatiramer acetate, discontinued prior disease-modifying therapy owing to unsatisfactory therapeutic effect, were treatment-naive, or had prior disease-modifying therapy duration of >1-3 years (P<=0.0301 for all comparisons vs placebo).	Fingolimod Hydrochloride	14-24	interferon beta 1	Homo sapiens	109-124